Derm-Biome Pharmaceuticals, Inc. Reports Positive Results from a Preclinical Study In Psoriasis
October 06, 2020 09:30 ET
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a private Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is...
Atopic Dermatitis Treatment Market to Grow Remarkably with Rising Awareness About Skin Problems, says Fortune Business Insights
September 21, 2020 07:35 ET
|
Fortune Business Insights
Pune, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The increasing advancement in atopic dermatitis and its rising prevalence are boosting the global atopic dermatitis treatment market, predicts Fortune...
ASLAN Pharmaceuticals Completes Enrolment in Second Cohort and Opens New Sites in US and Australia in ASLAN004 Atopic Dermatitis Study
September 21, 2020 06:00 ET
|
ASLAN PHARMACEUTICALS LIMITED
SINGAPORE, Sept. 21, 2020 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to...
ASLAN Pharmaceuticals Resumes Recruitment of New Patients Into ASLAN004 Study
August 24, 2020 03:27 ET
|
ASLAN PHARMACEUTICALS LIMITED
SINGAPORE, Aug. 24, 2020 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative...
Kymab Announces Positive Phase 2a Results for KY1005 in Moderate to Severe Atopic Dermatitis
August 11, 2020 04:06 ET
|
Kymab Group Ltd
Kymab Announces Positive Phase 2a Results for KY1005 in Moderate to Severe Atopic Dermatitis KY1005 met both primary end points demonstrating: A clinically meaningful improvement in disease activity...
Derm-Biome Pharmaceuticals, Inc raises pre-seed funding, spins out new company focused on chronic inflammatory diseases
July 02, 2020 11:00 ET
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, July 02, 2020 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on skin diseases and healthy ageing,...
MatriSys Bioscience Inc. is pleased to announce that we have been selected as a CONNECT 2020 Cool Company
May 28, 2020 14:11 ET
|
MatriSys Bioscience
SAN DIEGO, May 28, 2020 (GLOBE NEWSWIRE) -- MatriSys Bioscience, Inc., a leader in the field of microbiome-based therapeutics is pleased to announce that it was named a 2020 “Cool Company” by...
MatriSys Bioscience Inc. is pleased to announce that Magda Marquet PhD has been appointed Chairwoman of MatriSys’ Board of Directors
May 26, 2020 12:25 ET
|
MatriSys Bioscience
SAN DIEGO, May 26, 2020 (GLOBE NEWSWIRE) -- MatriSys Bioscience, Inc., a leader in the field of microbiome-based therapeutics, is pleased to announce that Magda Marquet PhD has been appointed...
Derm-Biome Pharmaceuticals, Inc. Reports Positive Results from a Preclinical Study In Atopic Dermatitis
March 24, 2020 08:00 ET
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, March 24, 2020 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a private Vancouver based start-up biopharmaceutical company focused on skin health and healthy...
New Eczema Report Depicts Enormous Burdens and Huge Unmet Medical Needs
March 18, 2020 11:00 ET
|
Asthma and Allergy Foundation of America
Washington, D.C., March 18, 2020 (GLOBE NEWSWIRE) -- Today, five organizations jointly release the “More Than Skin Deep” Voice of the Patient report summarizing outcomes from a September 2019...